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Endogenous  quaternary  ammonium  compounds  are  involved  in various  physiological  processes  in the
central  nervous  system.  In  the  present  study,  eleven  quaternary  ammonium  compounds,  including
acetylcholine,  choline,  carnitine,  acetylcarnitine  and  seven  other  acylcarnitines  of low  polarity,  were
analyzed  from  brain  extracts  using  a two  dimension  capillary  liquid  chromatography–Fourier  transform
mass  spectrometry  method.  To deal  with  their  large  difference  in hydrophobicities,  tandem  coupling
between  reversed  phase  and  hydrophilic  interaction  chromatography  columns  was  used  to  separate  all
the  targeted  quaternary  ammonium  compounds.  Using  high  accuracy  mass  spectrometry  in selected  ion
monitoring  mode,  all  the  compounds  could  be  detected  from  each  brain  sample  with  high  selectivity.  The
developed  method  was  applied  for  the  relative quantiﬁcation  of these  quaternary  ammonium  compounds
in  three  different  brain  regions  of tree  shrews:  prefrontal  cortex,  striatum,  and  hippocampus.  The  com-
parative  analysis  showed  that  quaternary  ammonium  compounds  were  differentially  distributed  across
the  three  brain  areas.  The  analytical  method  proved  to be  highly  sensitive  and  reliable  for  simultaneous
determination  of all  the  targeted  analytes  from brain  samples.
1. Introduction
Endogenous quaternary ammonium compounds (QACs) are
broadly distributed in various tissues including the central nervous
system, and many QACs have important biochemical functions in
brain [1,2]. For example, acetylcholine is a critical neuromodulator
that plays a key role in diverse cognitive functions [3,4]. Choline,
the product/precursor of acetylcholine, is  an important metabo-
lite [5] and can also act as a  nicotinic receptor agonist [6]. The
acylcarnitines are a  class of QACs that are  derivates of carnitine
[7]. Structurally, all carnitines, acetylcholine and choline share a
trimethyl quaternary ammonium group, and in  particular, acetyl-
carnitine bears very close structural resemblance to  acetylcholine
(see their structures in  Fig. 1). There are also a  number of doc-
umented functional links between carnitines and acetylcholine
in brain [1]. For example, acetylcarnitine can act as a source of
acetyl moieties and thus provide a  precursor for the production
of acetylcholine from choline [8–11]. In light of these interesting
structural and physiological links, our study targets developing a
mass spectrometry (MS)-based relative quantitative method that
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enables sensitive monitoring of acetylcholine, choline, free carni-
tine, acetylcarnitine and seven acylcarnitines of low polarity from
brain samples. We  apply this method to brain samples obtained
from tree shrews (Tupaia belangeri), a small mammalian species
that is  a  close relative of primates including humans.
MS is a  powerful method for the detection of QACs in electro-
spray mode (ESI) since QACs contain a  stably charged quaternary
ammonium group and thus exhibit high ionization efﬁciency [12].
To deal with the complexity of the biological samples, chromato-
graphic separations are required in  most cases to obtain high
detection capability and high reproducibility in  the analysis of
QACs. Until now, there is still no analytical method available that
allows the separation and detection of the targeted QACs in a sin-
gle LC–MS analysis. With different side chains, these QACs form
a class of molecules with different hydrophobicities, even though
they share the structural identity of their ammonium groups. This
hydrophobicity diversity poses challenges for the LC–MS anal-
ysis. Currently, the separation of QACs of high polarity, such
as choline, acetylcholine, carnitine and acetylcarnitine, are com-
monly conducted using hydrophilic interaction chromatography
(HILIC)–MS [13,14], ion-exchange chromatography [15,16], or ion-
pairing reversed phase (RP) chromatography [17–19]. To separate
carnitines of both low and high polarities, pre-column derivati-
zation has been used to  improve their separation on common RP


Published in -RXUQDORI&KURPDWRJUDSK\$
GRLMFKURPD
which should be cited to refer to this work.
ht
tp
://
do
c.
re
ro
.c
h
Fig. 1. Chemical structures of QACs analyzed and their accurate masses.
columns [20]. However, this method is only applicable to carnitines
but not to acetylcholine or choline because these two  QACs do not
have carboxyl group available for such derivatization.
In the present study, we  report a  sensitive and reliable capil-
lary liquid chromatography–Fourier transform mass spectrometry
(LC–FT-MS) method that allows relative quantiﬁcation of the tar-
geted QACs from brain tissue. The method uses a  simple, no-drying
sample preparation that facilitates the extraction of all the targeted
QACs from brain tissue. To deal with the analytical challenge caused
by the diverse hydrophobicities of the QACs, tandem coupling of
both RP and HILIC columns was used to separate all the targeted
analytes in a single LC–MS analysis. The mobile phase delivered to
MS was of high content acetonitrile and ion-pairing reagent free,
and thus permitted high detection capability for the QACs. Our
relative quantiﬁcation method was proven to be of high selectiv-
ity, sensitivity and reproducibility, allowing proﬁling each QAC of
interest in the different brain areas.
2. Experimental
2.1. Reagents
Choline (Ch) chloride, acetylcholine (ACh) chloride, carnitine
(Cart) hydrochloride and acetylcarnitine (ACart) hydrochloride
were purchased from Sigma–Aldrich (St. Louis, MO, USA). Propi-
onylcarnitine (PropioCart), hexanoylcarnitine (HexCart), octanoyl-
carnitine (OctCart), decanoylcarnitine (DecaCart), lauroylcarni-
tine (LauroCart), myristoylcarnitine (MyrCart) and palmitoyl-
carnitine (PalmCart) chloride were obtained from Tocris Bio-
science (Ellisville, MO,  USA). Choline-d9 chloride (Sigma–Aldrich),
acetylcholine-d4 chloride (Medical Isotopes Inc., Pelham, NH,
USA), carnitine-d3 hydrochloride, acetylcarnitine-d9 hydrochlo-
ride, octanoylcarnitine-d3 hydrochloride and palmitoylcarnitine-
d3 hydrochloride (Cambridge Isotope Laboratories Inc., Andover,
MA, USA) were used as internal standards (ISs). LC–MS grade formic
acid, ammonium hydroxide solution, methanol and acetonitrile
were supplied by Sigma–Aldrich. Water was obtained from a  Gen-
Pure water system (TKA, Niederelbert, Germany).
2.2. Preparation of standard and internal standard solutions
Individual standard and internal standard stock solutions
(1 mg/mL) were prepared in  20% methanol containing 0.1% formic
acid and stored at −20 ◦C. These stock solutions were diluted to
obtain a mixed standard and internal standard working solution
in 25% acetonitrile containing 0.3% formic acid that was  used to
characterize  the analytical performances of our tandem column
HPLC–MS system (each analyte and IS at 50 nM except for choline-
d9 at 1 M).  A mixed internal standard spiking solution in  20%
acetonitrile containing 0.1% formic acid was  also prepared from the
stock solutions (acetylcholine-d4, carnitine-d3, acetylcarnitine-d9,
octanoylcarnitine-d3, palmitoylcarnitine-d3 at 1 M and choline-
d9 at 20 M).
2.3. Animals and sample preparation
Tree shrews (T.  belangeri) were used in this study (n  = 3). The
animals were housed under constant temperature and humidity
with free access to  food and water. The handling of the animals
and the experimental procedures were approved by the veterinary
ofﬁce of Fribourg, Switzerland. The tree shrews were sacriﬁced
by decapitation after anesthetization with ketamine (100 mg/kg,
Streuli Pharma AG, Uznach, Switzerland). The head was imme-
diately heated up to  80 ◦C in 16 s using microwave irradiation
[21]. The brains were rapidly removed from the cranium and
three areas (prefrontal cortex, striatum and hippocampus) were
dissected. The tissues of each area were collected from three dif-
ferent animal brains and then pooled together, homogenized by
the automated Precellys 24 homogenizer (Bertin Technologies,
Montigny-le-Bretonneux, France) and divided in three samples that
were  processed separately. The striatum and hippocampus tissues
(each 30 mg)  were successively spiked with 20 L  of the mixed
internal standard spiking solution. The prefrontal cortex tissues
(each 20 mg)  were spiked with 13.3 L of the mixed internal stan-
dard spiking solution. The tissues were then homogenized in the
Precellys 24 homogenizer, using ice-cold acetonitrile containing
0.3% formic acid (100 L  for striatum and hippocampus sam-
ples and 66.7 L  for prefrontal cortex samples). The homogenates
were centrifuged at 22,000 × g for 20 min  at 4 ◦C. The super-
natants  were collected and ﬁltered by 0.20 m ﬁlter membranes
(Millex-LG, Millipore, Billerica, MA,  USA). The ﬁltered supernatants
were diluted four times with water containing 0.3% formic acid
before the analysis. The ﬁnal concentrations of acetylcholine-d4,
choline-d9, carnitine-d3, acetylcarnitine-d9, octanoylcarnitine-d3
and palmitoylcarnitine-d3 in  each sample was 50 nM,  1000 nM,
50 nM,  50 nM,  50 nM and 50 nM,  respectively.
2.4.  Tandem column FT-MS analysis
In this study, a  NanoLC-2D system (Eksigent, Dublin, CA, USA)
coupled to  a LTQ-Orbitrap Discovery mass spectrometer (Thermo
Fisher Scientiﬁc, Bremen, Germany) was used. The two  inde-
pendent binary gradient pumps of our  LC arrangement allowed
achieving a two-dimensional separation and efﬁcient online sol-
vent mixing without the use of a  second HPLC system. A capillary
RP column and a  HILIC column were coupled in a  tandem mode
through a  nano T-piece. One of the ports of the T-piece was  con-
nected to the capillary pump (Channel 1) in the Eksigent LC. The
inlet line of the RP column was  connected to the autosampler,
which was coupled with the nanoﬂow pump (Channel 2) in the
Eksigent LC. The outlet line of the HILIC column was  coupled
with the ESI-MS source. For the primary separation, a  C18 column
(100 mm  × 150 m I.D.) packed with 5 m particles (ReproSil-
Pur C18 AQ, Dr. Maisch GmbH, Ammerbuch-Entringen, Germany)
was used and the secondary separation was  performed with an
HILIC column (250 mm  ×  200 m I.D.) with 5 m particles (Poly-
hydroxyethyl Aspartamide, PolyLC, Columbia, MD,  USA). The RPLC
mobile phase was  composed of 0.2% formic acid in water (A) and
acetonitrile (B) using the following gradient program at a  ﬂow
rate of 0.4 L/min: 0–10 min, linear gradient 2–30% (B); 10–25 min,
linear gradient 30–70% (B); 25–35 min, linear gradient 70–90%
(B); 35–40 min, returning linear gradient 90–2% (B); 40–45 min,
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isocratic 2% (B). The HILIC mobile phase composition was  1% formic
acid, 50 mM ammonium hydroxide in  water (A) and 0.2% formic
acid, 10 mM ammonium hydroxide in  95% acetonitrile (B). To the
RPLC mobile phase run-out ﬂow of 0.4 L/min, the following HILIC
gradient at a ﬂow rate of 3 L/min was added via a  T-piece:
0–3  min, isocratic 99% (B); 3–12 min, linear gradient 99–60% (B);
12–25 min, isocratic 60% (B); 25–40 min, returning linear gradi-
ent 60–99% (B); 40–45 min, isocratic 99% (B). A pre-equilibration
period  of 10 min  was used between each run and the injection vol-
ume was 1 L. The LTQ-Orbitrap mass spectrometer was equipped
with a nano-electrospray ion source operating in positive ion mode.
For the nanospray ionization, the two-column system was con-
nected to a tip emitter (stainless steel, O.D. 150 m, I.D. 30 m,
Thermo Fisher Scientiﬁc). The ion spray voltage was 1.8 kV, the
capillary temperature was set at 300 ◦C and the capillary volt-
age was 31 V. To increase the sensitivity of the mass analysis,
the acquisition was performed in  selected ion monitoring (SIM)
mode, which was a  data acquisition mode conducted in the ion
trap for ion ﬁltration and accumulation. For each analyte investi-
gated, a SIM scan event was used in  which the scan range was  set
as M+ ± 1 m/z.
The  mass spectrometer was calibrated using the manufacturer’s
calibration standard mixture. The SIM mass spectra were acquired
in proﬁle mode with a  setting of 30,000 resolution (FWHM) at m/z
400. The entire LC/MS system and data processing were performed
using Xcalibur software (Thermo Fisher Scientiﬁc). Each QAC peak
area was integrated using the extraction ion chromatogram (EIC)
technique in which each chromatogram is  deﬁned by  its charac-
teristic mass peak within 10 ppm mass tolerance. The QACs were
relative quantiﬁed by  calculating the peak area ratio of a QAC to
its corresponding internal standard. Choline, acetylcholine, car-
nitine, acetylcarnitine, octanoylcarnitine and palmitoylcarnitine
were quantiﬁed using their own stable isotope-labeled internal
standards. Propionylcarnitine was quantiﬁed using the acetylcar-
nitine internal standard; hexanoyl-, decanoyl- and lauroylcarnitine
with the octanoylcarnitine internal standard and myristoylcarni-
tine with the palmitoylcarnitine internal standard. Each extract
from different brain areas of three tree shrews was  analyzed for
four times. The peak area ratio between an analyte and its cor-
responding internal standard was then averaged for comparative
analysis (n = 12).
3. Results and discussion
3.1.  Sample preparation
Sample  preparation has a  critical inﬂuence on the detection
capability and reproducibility of the analytical method. In the
present study, the animal brains were immediately stabilized using
microwave irradiation to  prevent the degradation of QACs in the
post-mortem period. In order to  extract the analytes from brain
tissue with low content of salts and proteins, the sample prepara-
tion was conducted using 100% acetonitrile with 0.3% formic acid
[22] but without any drying treatment.
A large number of studies have showed that, in  post-mortem
period, enzymes can rapidly cause the degeneration of some tissue
components such as proteins and peptides in the brain [23,24]. The
degeneration alters the levels of these endogenous compounds and
leads to false estimates of their actual amounts. In the brain, acetyl-
choline can be rapidly decayed to  choline under the hydrolysis
of acetylcholinesterase [2]. Similar mechanism exists for acylcar-
nitines [1]. Tissue stabilization using microwave heating or related
techniques is commonplace in  proteomics studies, but has not  been
widely applied for stabilization of neurotransmitter levels. The
application of microwave irradiation proved to rapidly terminate
the  enzyme activity and thus maintain the levels of endogenous
components in the brain tissue [21].
Currently, various extraction methods are used for the extrac-
tion of acetylcholine, choline and/or carnitines. These methods
include solid phase extraction [17], liquid–liquid extraction [18,25],
or acidiﬁed solvent extraction [22]. Liu and Pasquali [22] described
an extraction method that used acidiﬁed acetonitrile followed by
drying treatment. This method allowed acylcarnitines to be well
extracted with low level of interferences from salts and proteins,
because of the use of high content of organic solvents [26,27]. In
our study, we found that the use of a drying treatment did not
allow us to detect several long-chained, hydrophobic carnitines
such as myristoylcarnitine and palmitoylcarnitine. They may  be
irreversibly absorbed by the matrix or other materials such as
the ﬁlter or vials during the drying treatment and the subsequent
reconstitution processing, resulting in highly variable and unre-
liable estimates speciﬁcally for these compounds. In contrast, our
extraction method, which did not use a  drying step, allowed myris-
toylcarnitine and palmitoylcarnitine to be extracted along with
other QACs, which in turn allowed them to  be readily detected
by using our newly developed LC–MS method (discussed in the
following sections).
3.2.  RP–HILIC–FT-MS analysis
To  acquire the separation of all the targeted QACs in  a  single
HPLC–MS run, we developed a  tandem capillary column coupling
system. In  this setup, the RP column acted as the ﬁrst column to
separate QACs of low polarity such as palmitoylcarnitine, while
the HILIC column worked as the second column to separate QACs
of high polarity, including acetylcholine, choline, acetylcarnitine,
and carnitine. As the system used direct coupling between the two
columns, the adjustment of the ﬂow rate and the mobile phase
composition was  thus required to  keep the system working appro-
priately. To retain the polar compounds in HILIC, the content of
acetonitrile in the eluate from the RP column was enhanced by
online mixing with high content of acetonitrile solvent. As the HILIC
column is coupled post the RP column, the pre-column pressure
of the RP column will be  inevitably high due to  the cumulative
effect of the backpressure on the two columns. To make the sys-
tem works at the appropriate pressure range, the RP column had a
smaller diameter and shorter length than the HILIC column. In  the
experiments, the mobile phase for the RP column was delivered
at 0.4 L/min by using the nanoﬂow pump of the two dimension
LC, while the online mixing solution was  delivered at 3  L/min by
using a  capillary pump. After online mixing, the calculated con-
tent of acetonitrile in  the initial mobile phase on the HILIC column
was around 83%, which was high enough for maintaining the HILIC
separation mechanism. The proﬁles of the mobile phase gradient
were controlled by a single software. This setup enabled to  sep-
arate and detect all the QACs of interest from the brain extracts
(see Fig. 2 the LC–MS analysis of brain extract). In the experiments,
all the analytes were measured by high resolution mass spectrom-
etry and identiﬁed within 10 ppm mass tolerance and with their
characteristic retention time compared to their standards [28,29].
It  remains a  challenging task to  develop a  fast  and reliable
analytical method that allows the simultaneous determination of
groups of compounds with different polarities, e.g.,  QACs targeted
in the present study. Ion-pairing chromatography methods have
been described for the analysis of the acylcarnitines as well as
for acetylcholine and choline [18,19]. However, the use of  buffers
and ion-pair reagents commonly requires long condition time
for columns when using gradient elution proﬁle. It  could also
suppress the ESI process and diminish the signal intensity, which
may demand complex sample preparation steps such enrichment
of QACs. Recent studies showed that RP–LC–MS could be directly
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Fig. 2. Representative chromatograms of a striatum extract. The capillary RP–HILIC–FT-MS setup allows the separation and detection of all the targeted QACs in striatum.
The RP column provides separation for hydrophobic QACs including hexanoylcarnitine, octanoylcarnitine, decanoylcarnitine, lauroylcarnitine, myristoylcarnitine and palmi-
toylcarnitine. The HILIC column provides separation for acetylcholine, choline, carnitine, acetylcarnitine and propionylcarnitine. The striatum sample is prepared using 16 L
solution  per 1 mg of tissue. Each QAC was  detected with signal to  noise ratio 10.
used for analysis of acylcarnitines but not  free carnitine, acetyl-
choline or choline [30], while HILIC–MS allowed polar QACs such
as acetylcholine and choline to be separated and detected [13,14].
Although a recent study has shown that acetylcarnitine and palmi-
toylcarnitine could be analyzed using HILIC–MS [31], the elution
times of the two QACs were short and very close, reﬂecting the low
separation and peak capability of HILIC–MS for a  large number of
QACs, in particular for hydrophobic ones. In contrast, our results
showed that the direct coupling between RP and HILIC columns
allowed good separation of multiple QACs, despite large differ-
ences in hydrophobicity. Compared to other 2D-LC setups [32–36],
our system was relatively simple and easy to operate. The sys-
tem did not use an extra valve between the two columns, and
all the ﬂow rates were controlled by  a  single 2D nanoLC system.
The system also retains the advantage of HILIC for highly sensi-
tive detection, because the high organic mobile phase content used
in HILIC facilitates the desolvation and compound ionization in the
electrospray process. In addition, the use of capillary columns could
also increase the sensitivity in  the detection of QAs compared to
standard columns, because of their small diameters.
In our study, the nine carnitines, together with acetylcholine
and choline were selected regarding their biological relevance dur-
ing cholinergic transmission and related energy metabolism. They
together represented compounds of a  large range of hydropho-
bicities. Our developed RP–HILIC–FT-MS method showed good
peak capacity for separation of not only polar carnitines, but also
hydrophobic carnitines. In the brain exist various carnitines with
different chain lengths. As most other carnitines have median or
long acyl chains and consequently have higher hydrophobicities
than the free carnitine, these carnitines could thus be also retained
and separated, if necessary, on the ﬁrst C18 column of our system.
3.3. Analysis of tree shrew brain extracts
Having achieved the separation of the targeted analytes on
the tandem column system, the method was further tested to
evaluate its suitability for a relative determination of the targeted
QACs in three different brain regions (striatum, prefrontal cor-
tex and hippocampus). Each QAC was detected in  selected ion
monitoring  (SIM) mode and the peak area was  integrated using the
extraction ion chromatogram (EIC) technique with 10 ppm mass
tolerance. The analytes were relative quantiﬁed by measuring the
peak area ratio of a QAC to  its corresponding internal standard.
The  stability of a  two  dimension LC–MS is  very important for
continuous quantitative analysis of large set of biological samples.
Our capillary RP–HILIC–MS system allowed continuous analysis of
the brain tissue extracts for a  period lasting up to two weeks. The
high stability could be mainly attributed to the sample prepara-
tion procedure. In  complex biological samples, some substances do
not dissolve well in high content of organic solvents and therefore
have to  be  removed prior to  HILIC analysis. Our initial tests showed
that the brain tissue extracts obtained using low content of ace-
tonitrile could often result in the blockade of the HILIC column. In
contrast, our current sample treatment was able to efﬁciently avoid
this issue because brain tissues were extracted with high content
of acetonitrile and diluted with high content of water. In this way,
the substances that are poorly soluble in high content acetonitrile
or water were removed in  the sample preparation step.
The  SIM analysis conducted on FT-MS allowed each QAC
detected with high intensity and high stability. The present study
targeted developing a relative, rather than an absolute, quantita-
tive method for differential analysis of multiple QACs in the brain.
Thus some analytical characteristics, such as the recovery and LOD,
were not determined as required in an absolute quantitative anal-
ysis. Although LOD was not measured in the present study, we
checked the MS  signal to noise ratio of each analyte and found all
of them were much higher than 10 in the brain samples, a high
value allowing differential analysis. Similar to  relative quantita-
tive analysis studies commonly conducted in metabolomics and
proteomics for endogenous substances [37–39], we monitored the
CVs of analyte peak area/IS peak area ratios for quality control [40].
Using three technical replicates prepared from homogenized tis-
sues (see Section 2), we were able to  demonstrate the high precision
of our method as shown by coefﬁcients of variation (CVs) among
measurements of under 17% for all the QACs (see Fig. 3).
We  further examined the regional distribution of the QACs
within the three brain regions. Interestingly, we observed pro-
nounced differences in the levels of some QACs across the different
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Fig. 3. Average relative amounts of the QACs (analyte peak area/IS peak area) in
striatum, prefrontal cortex and hippocampus of three tree shrew brains. The values
were expressed as mean ± s.e.m. The  ﬁnal concentration of internal standard choline
d9  in each sample was  1 M. The concentrations of other internal standards were
50  nM.
brain areas (see Fig. 3). The highest content of acetylcholine was
found in the striatum followed by  hippocampus and prefrontal
cortex. These results are consistent with previous ﬁndings in  rat
and mouse brain, obtained using pyrolytic gas chromatographic
methods [41,42]. Our ﬁndings are also consistent with the known
anatomical distribution of cholinergic neurons, as the striatum con-
tains many cholinergic interneurons and the hippocampus is a
major projection target of cholinergic cells originating in  the medial
septum [43].
We  also found differences in the distribution of the acyl-
carnitines in the three brain regions. While carnitine and the
short-chain acetylcarnitine and propionylcarnitine exhibited rela-
tively little variation in  their regional levels, differences were more
pronounced for medium- and long-chain acylcarnitines. These
QACs showed similar results to acetylcholine, with higher levels
in striatum and hippocampus than in prefrontal cortex. Interest-
ingly, the differential expression between brain areas appeared
to correlate with QAC chain length, with highest values observed
for long-chained compounds including decacarnitine, lauroylcar-
nitine, myristoylcarnitine and palmitoylcarnitine.
Only few studies have so far addressed the differential distri-
bution of carnitine and its acyl derivatives in  speciﬁc brain regions
[44,45], although these studies have generally not distinguished
among different long-chained acylcarnitines. In agreement with
our results, these studies have also shown a  heterogeneous dis-
tribution of long-chain acylcarnitines in  the areas investigated,
with low content observed in  the frontal cortex and high content
observed in regions not  examined in the present study such as the
cerebellum and hypothalamus [44].
Taken together, the results obtained with our  method are
consistent with the available literature. QACs carry out impor-
tant functions in brain and central nervous system, contributing
for example to neural activity, membrane plasticity, energy
metabolism and protein modiﬁcation. Our method is suited for
future studies of QAC involvement in  physiological and biochemical
pathways related to these processes.
4. Conclusions
We  have presented an integrated method for the analysis of
multiple endogenous QACs. This method allows 11 QACs extracted,
separated and detected from homogenized brain extracts. Although
these QACs have very different hydrophobicities, their separations
are facilitated by using the tandem connection of both reversed
phase column and HILIC column. The combinational use of  high
accuracy MS and tandem capillary columns permits the detection
of targeted QACs with high selectivity and sensitivity. Our relative
quantitative method allowed proﬁling QACs in  the different brain
areas of tree shrews. Due to the functional importance of QACs in
the brain and central nervous system, we  anticipate the application
of our method in  basic neuroscience and pharmaceutical research.
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